Aprea Therapeutics, Inc. - Common Stock, par value $0.001 per share (APRE)

CUSIP: 03836J102

Q4 2021 13F Holders as of 31 Dec 2021

Holder snapshot 7 signals
Share change
-1,347,069
Put/Call ratio
75%
SEC-reported price per share
$2.87
Number of holders
35
Value change
-$8,428,012
Number of buys
18
Open additional details 1 more signal available
Number of sells
18
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
228,836,687

Security key

03836J102

Report period

Q4 2021

Institutions

35

Top holders

10

Ownership snapshot

Top reported holders of APRE - Aprea Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Versant Venture Managemen...
Disclosed value leader
Versant Venture Managemen...
Comparable rows
15/15
Latest evidence
30 Sep 2021
13F Lead comparable stake: 0.55% Showing 1-6 of 15 holder rows.

Quick read

Versant Venture Management, LLC leads the comparable SEC ownership view at 0.55%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Versant Venture Management, LLC's linked filing trail.
Comparable ownership Top 5
Versant Venture Management, LLC 0.55%
VANGUARD GROUP INC 0.31%
Redmile Group, LLC 0.3%
BlackRock Finance, Inc. 0.15%
KENNEDY CAPITAL MANAGEMENT LLC 0.15%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Versant Venture Management, LLC
13F
Company
13F
0.55%
$6,437,000
1,259,662 shares
30 Sep 2021
VANGUARD GROUP INC
13F
Company
13F
0.31%
$3,665,000
717,415 shares
30 Sep 2021
Redmile Group, LLC
13F
Company
13F
0.3%
$3,551,000
694,918 shares
30 Sep 2021
BlackRock Finance, Inc.
13F
Company
13F
0.15%
$1,811,000
354,275 shares
30 Sep 2021
KENNEDY CAPITAL MANAGEMENT LLC
13F
Company
13F
0.15%
$1,750,000
342,486 shares
30 Sep 2021
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
13F
0.09%
$1,020,000
199,653 shares
30 Sep 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
35
Shares
3,610,494
Rows available
35
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
37
Q4 2021 holders
35
Holder diff
-2
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 value Q4 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .